Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More

Baxter stock tumbled Tuesday after the medtech company agreed to sell its kidney segment to Carlyle for $3.8 billion. The post Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More appeared first on Investor's Business Daily.

Aug 13, 2024 - 15:25
 0  9
Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors
Expected More

Baxter stock tumbled Tuesday after the medtech company agreed to sell its kidney segment to Carlyle for $3.8 billion.

The post Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More appeared first on Investor's Business Daily.

iShook Opinion "iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.